Summary
This prediction ended on 01.03.25 with a price of €22.88. With a performance of 6.00%, the BUY prediction by VentureBank61 for Bayer AG closed with a slight gain. VentureBank61 has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bayer AG | 3.648% | 3.648% | 90.578% |
| iShares Core DAX® | 1,00 % | 4,83 % | 8,15 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % | 26,92 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % | 48,06 % |
| iShares S&P 500 | 1,77 % | 1,27 % | 23,58 % |
Comments by VentureBank61 for this prediction
In the thread Trading Bayer AG
Die von VentureBank61 gewählte maximale Laufzeit wurde überschritten